Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CEO's ARE judged based on PPS and rightly so

"The time to judge RG is in the future not now. I would say two more years would be a good time to judge RG's performance. That should be enough time for The USPTO and for some of the companies that PTSC has invested in to perform."

So, you're saying, we should wait another two years with this maybe further decreasing shareprice?

Of course the main responsibility of a CEO is to build a solid company with future, but also it's to increase the value of his company. Therefore he should be able to answer the question, what he thinks of the 85% loss since his start and what he wants to do to change this - in short and long term.

And I have to say it once again: I know a little bit, how the software business works and it's no wonder, we don't see masses of investors buying in PTSC. Because the strategy of the "new PTSC" is NOT exciting, at least not TODAY. This may change, if the MMP generates money and RG is able to purchase some additional companies.

But my main critizism with RG is not only the loss of PTSC's value, it's my assumption, that he was fully aware, what would happen to the shareprice in the future, when he started in Feb 2008. Sorry, that this sounds like a conspiracy theory, but I'm convinced his early purchases of shares in March 08 were part of another game of leading the shareholders in the wrong direction.

Anyway, the only question left to us is: How can one handle the disappointing situation?

I have to admit, the days I had a positive feeling about PTSC have become less and less....glta

Share
New Message
Please login to post a reply